Table 5 Univariate and multivariate logistic regression analysis to predict pathologic Gleason score upgrading among PIRADS ≤ 2 patients
From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
| Â | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
OR | 95%CI | p-value | OR | 95%CI | p-value | |
Age | 1.021 | 0.958–1.088 | 0.523 |  |  |  |
Bdoy mass index | 1.100 | 0.925–1.307 | 0.280 |  |  |  |
DM | 0.804 | 0.198–3.261 | 0.760 |  |  |  |
HTN | 0.981 | 0.394–2.440 | 0.967 |  |  |  |
Prostate volume | 0.984 | 0.962–1.007 | 0.173 |  |  |  |
PSA | 0.991 | 0.844–1.164 | 0.915 |  |  |  |
PSA density | 1.811 | 0.688–4.764 | 0.329 |  |  |  |
Number of biopsy (12 vs. ≥ 13) | 0.615 | 0.196–1.933 | 0.406 |  |  |  |
Mean percentage of positive core | 3.400 | 1.010–11.451 | 0.048 | 0.962 | 0.905–1.022 | 0.206 |
Mean tumor length | 6.500 | 2.114–19.987 | 0.001 | 11.336 | 1.630–78.845 | 0.014 |
Mean percentage of total tumor of core | 3.274 | 1.210–8.861 | 0.020 | 1.042 | 0.976–1.112 | 0.220 |